These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16920103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM, Bonafonte MT, Campbell LD, Mead JR.
    Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
    [Abstract] [Full Text] [Related]

  • 4. Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice.
    Ehigiator HN, Romagnoli P, Borgelt K, Fernandez M, McNair N, Secor WE, Mead JR.
    Parasite Immunol; 2005 Jul; 27(1-2):17-28. PubMed ID: 15813719
    [Abstract] [Full Text] [Related]

  • 5. Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum.
    Jakobi V, Petry F.
    Parasite Immunol; 2008 Mar; 30(3):151-61. PubMed ID: 18179628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-gamma and interleukin-12-deficient mice to naive recipients.
    Tessema TS, Dauber E, Petry F.
    Vaccine; 2009 Nov 05; 27(47):6575-81. PubMed ID: 19717136
    [Abstract] [Full Text] [Related]

  • 9. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection.
    Lacroix S, Mancassola R, Naciri M, Laurent F.
    Infect Immun; 2001 Mar 05; 69(3):1635-42. PubMed ID: 11179338
    [Abstract] [Full Text] [Related]

  • 10. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice.
    Smith LM, Bonafonte MT, Mead JR.
    J Parasitol; 2000 Apr 05; 86(2):300-7. PubMed ID: 10780549
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cryptosporidium parvum: the course of Cryptosporidium parvum infection in C57BL/6 mice co-infected with the nematode Heligmosomoides bakeri.
    Bednarska M, Bajer A, Sinski E.
    Exp Parasitol; 2008 Sep 05; 120(1):21-8. PubMed ID: 18522859
    [Abstract] [Full Text] [Related]

  • 13. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
    Li Y, Ishii K, Hisaeda H, Hamano S, Zhang M, Nakanishi K, Yoshimoto T, Hemmi H, Takeda K, Akira S, Iwakura Y, Himeno K.
    Gene Ther; 2004 Jun 05; 11(11):941-8. PubMed ID: 14985787
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
    Alak JI, Wolf BW, Mdurvwa EG, Pimentel-Smith GE, Kolavala S, Abdelrahman H, Suppiramaniam V.
    Cell Mol Biol (Noisy-le-grand); 1999 Sep 05; 45(6):855-63. PubMed ID: 10541481
    [Abstract] [Full Text] [Related]

  • 16. Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection.
    Wang C, Luo J, Amer S, Guo Y, Hu Y, Lu Y, Wang H, Duan M, He H.
    Vaccine; 2010 Dec 16; 29(2):323-8. PubMed ID: 21029808
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting.
    Farah CS, Hu Y, Riminton S, Ashman RB.
    Oral Microbiol Immunol; 2006 Aug 16; 21(4):252-5. PubMed ID: 16842510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.